🎉 Finosauras is now  SarasRead more
Glenmark Life Sciences Ltd logo

Alivus Life Sciences Limited - Tomorrow Price Target

(NSE: ALIVUS)

Sector: Chemicals

Market Cap: 10577.42 Cr

973.25

-

902.30

Tomorrow Target Price Range

883.50

+22.00 (2.49%)

CMP

Bearish

As on 23 Jan 2026, 03:30 pm

Market Trends

Based on 6 technical indicators.
Bullish2
Bearish3
Neutral1
Agg. Profit Potential10.15%
Agg. Risk 5.91%

Last updated on: 24/01/2026, 3:30 pm

Returns

PeriodReturn %
1 Month-1.20
3 Months-5.08
1 Year--
5 Years--

Last updated on: 09/01/2026, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
Quant Mutual Fund - Quant Healthcare Fund2.51%3,080,136
Government Pension Fund Global2.09%2,563,000
ICICI Prudential Pharma Healthcare and Diaganostic1.29%1,576,606
Massachusetts Institute of Technology1.23%1,504,000

Last updated on: 12/31/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

19.45

P/B Ratio

3.51

PEG Ratio

8.73

ROE

18.94%

EPS

44.30

Dividend Yield

0.58%

Market Cap

10577.42 Cr

Sector

N/A

Last Updated: 23 Jan 2026, 02:30 pm

Loading peer comparison...

About : Alivus Life Sciences Ltd.

Incorporated Year

2011

City and State

Solapur, Maharashtra

Listing Date

Director's Name

Rudalf Corriea

Revenue

2396.75 Cr

Net Profit

485.63 Cr